Fragment-Based Drug Discovery: Difference between revisions
No edit summary |
No edit summary |
||
Line 16: | Line 16: | ||
•<scene name='Sandbox_reserved_394/Tyrosine_199/3'>Tyr199</scene> | •<scene name='Sandbox_reserved_394/Tyrosine_199/3'>Tyr199</scene> | ||
•<scene name='Sandbox_reserved_394/Valine_145/1'>Val145</scene> | •<scene name='Sandbox_reserved_394/Valine_145/1'>Val145</scene> | ||
•<scene name='Sandbox_reserved_394/Leucine_134/1'>Leu134</scene> | |||
•<scene name='Sandbox_reserved_394/Phe109_and_ala108/1'>Phe109</scene> | |||
•<scene name='Sandbox_reserved_394/Phe109_and_ala108/1'>Ala108</scene> | |||
</StructureSection> | </StructureSection> |